Analytical Data
-
基因名
SCUBE3
- Application
-
别名
CEGF3; CUB Domain And EGF-Like Repeat Containing 3; Signal peptide, CUB and EGF-like domain-containing protein 3
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8IX30
-
表达区间
Glu807~Lys993
-
分子量
26kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SCUBE3 (Signal peptide, CUB domain, EGF-like 3) is a significant protein involved in various biological processes, including cell signaling, developmental biology, and tumorigenesis. Studies have shown that SCUBE3 plays a critical role in the regulation of the WNT/β-catenin signaling pathway, which is crucial for embryonic development and cellular differentiation. Dysregulation of SCUBE3 has been implicated in several cancers, making it an important target for therapeutic research. The protein is characterized by its unique structure, featuring multiple CUB and EGF-like domains, which contribute to its interactions with other proteins and influence cellular functions. Understanding the mechanisms underlying SCUBE3's actions at a molecular level is essential for elucidating its role in normal physiology and disease. Therefore, research efforts are increasingly focused on the recombinant expression of SCUBE3, allowing for detailed functional studies and potential drug development strategies. Through these advancements, researchers aim to unveil the therapeutic potential of SCUBE3-targeted interventions in cancer and other diseases influenced by aberrant signaling pathways.
